Vaxabov B.M., “HYPERLIPIDEMIA-SPECIFIC BIOMARKERS WOULD IMPROVE CLINICAL DIAGNOSIS AND THERAPEUTIC TREATMENT AT EARLY DISEASE STAGES”., jasass, vol. 15, no. 12, pp. 627–630, Dec. 2025.